动脉化疗栓塞联合射频消融与手术切除对早期HCC患者生存率影响的Meta分析

目的 评价动脉化疗栓塞(TACE)联合射频消融(RFA)与手术切除(SR)治疗早期肝细胞性肝癌(HCC)的有效性与安全性.方法 计算机检索PubMed、Medline、Embase、中国生物医学数据库、万方数据库、维普数据库和中国期刊全文数据库.收集2000年1月至2016年3月TACE联合RFA(TACE-RFA组)与SR(SR组)治疗早期HCC的前瞻性或回顾性研究.结果 纳入4个随机或非随机同期对照试验共697例患者,TACE-RFA组患者的1、3年总体生存率(OS)为94.40％ (337/357)、59.94％(214/357),SR组为92.35％ (314/340)、68.24％ (232/340),两组比较差异无统计学意义(OR=1.43,95％CI:0.79～2.60,P=0.24,I2=0％;OR=0.77,95％CI:0.56～1.07,P=0.12,I2=45％).TACE-RFA组患者与SR组的1年无复发生存率(RFS)比较差异无统计学意义(81.51％ vs.80.29％,OR=1.07,95％CI:0.73～1.57,P=0.74,I2=0％);但TACE-RFA组患者的3年RFS明显低于SR组(29.97％ vs.44.41％,OR=0.56,95 ％CI:0.40～0.77,P=0.000 5,I2=0％).TACE-RFA组患者的严重并发症发生率明显低于SR组(1.43％ vs.5.07％,OR=0.23,95 ％CI:0.10～0.54,P=0.000 7,I2=10％).结论 外科手术较TACE-RFA能明显降低早期HCC的远期复发率,且严重并发症发生率较手术科手术低.

Influence of transarterial chemoembolization combined radiofrequency ablation and surgical resection on survival rate in patients with early hepatocellular carcinoma:a Meta analysis

Objective To evaluate the effectiveness and safety of transarterial ehemoembolization(TACE) combined with radiofrequency ablation(RFA) and surgical resection(SR) in the treatment of early stage hepatocellular carcinoma(HCC).Methods PubMed,Medline,Embase,China biomedical database,Wanfang database,CQVIP database and Chinese Journal Full-text database were retrieved by computer.Prospective or retrospective studies of TACE combined with RFA and SR for treating early HCC published from January 2000 to March 2016 were collected.Results Four randomized or non-randomized concurrent controlled trials were included,involving 697 patients.The 1-year and 3-year overall survival(OS) rates in the TACE-RFA group were94.40％(337/357) and 59.94％(214/357),which in the SR group were 92.35％(314/340) and 68.24％ (232/340),the difference between the two groups was not statistically significant(OR=1.43,95％CI:0.79-2.60,P=0.24,I2 =0％;OR=0.77,95％CI:0.56-1.07,P=0.12,I2 =45％).The 1-year relapse-free survival(RFS) rate of the TACE-RFA group and the SR group was similar 81.5％(291/357) vs.80.3％(273/340),OR=1.07,95％CI:0.73-1.57,P=0.74,I2=0％],while the 3-year RFSrate of the TACE-RFA group was obviously lower than that of the SR group(29.97％ vs.44.41％,OR=0.56,95％CI:0.40-0.77,P=0.000 5,I2 =0％).The incidence rate of severe complications in the TACE-RFA group was evidently lower than that in the SR group(1.43％ vs.5.07％,OR=0.23,95％CI:0.10-0.54,P=0.000 7,I2 =10％).Conclusion Compared with TACE-RFA,SR can significantly reduce the long term recurrence rate of early stage HCC,but the occurrence rate of severe complications in SR is higher than that in TACE-RFA.